3 Shares Analysts Hate: Royal Bank of Scotland Group plc, Unilever plc And Wm. Morrison Supermarkets plc

Why Royal Bank of Scotland Group plc (LON:RBS), Unilever plc (LON:ULVR) and Wm. Morrison Supermarkets plc (LON:MRW) are out of favour with City experts.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

RBSProfessional analysts have more time, more data, and better access to companies than most private investors. As such, the wisdom of the City crowd is worth paying attention to; because, at the end of the day, you’re either going with the pros or going against them when you invest.

Right now, Royal Bank of Scotland Group (LSE: RBS) (NYSE: RBS.US), Unilever (LSE: ULVR) (NYSE: UL.US) and Wm. Morrison Supermarkets (LSE: MRW) are among the most unfavoured stocks of the professional analysts.

Royal Bank of Scotland

RBS pre-released a set of forecast-thumping first-half numbers on 25 July, a week ahead of the group’s formal half-year report. The early release sparked an 11% spike in the shares amid what analysts at Investec called “wild euphoria”.

However, while many City experts have upgraded their full-year forecasts, there hasn’t been a major change to the balance of buy, hold, and sell recommendations. RBS remains the bank analysts love to hate: sell recommendations outweigh buys by five to one.

A couple of analysts have moved from sell to hold, but Investec has gone the other way to join the bear camp. Investec is not alone in believing market sentiment has “got ahead of financial reality”, but is more forthright in suggesting “investors should again feel able to short the stock with confidence”.

RBS trades on a forward P/E of 13.6 at a share price of 353p, which is much richer than its rivals; and there’s no dividend either.

Wm. Morrison Supermarkets

The recent announcement of the departure of Tesco chief executive Philip Clarke has been broadly welcomed by the City. Even though analysts acknowledge Tesco’s problems haven’t gone away, and that the risk of a dividend cut has now actually increased, City sentiment has improved — albeit remaining on the bearish side.

In contrast, the vast majority of analysts see only black clouds on the horizon for Morrisons, which is firmly established as the City experts’ most unloved supermarket. Getting on for two thirds of analysts now rate Morrisons a sell compared with nearer one third a year ago.

Morrisons is on a forward P/E of 14 at a share price of 168p, well above the ratings of Tesco and J Sainsbury, which stand at 10 and 10.4 respectively.

Unilever

Most analysts have consumer goods giant Unilever marked as a hold, but a growing minority have moved to sell over the last year. The number of bears has doubled from three to six, and the proportion now rating Unilever a sell has risen to almost one third.

This is a far bigger cadre of bears than we find at rival Reckitt Benckiser, or at companies in the wider consumer goods sector, such as British American Tobacco and Diageo.

There were a few positives — on margins and earnings — in Unilever’s recent half-year results, but some analysts preferred to focus on sales volume growth, which remained at 1.9% quarter-on-quarter versus an expected Q2 gain of 2.4%. Analysts at RBC Capital Markets said: “The absence of quarter-on-quarter acceleration is disappointing”.

With short-term pressure on analysts’ forecasts on the downgrade side, as a result of the ongoing intensely competitive environment Unilever finds itself in, it’s hard to argue against the view of even neutral analysts such as Canaccord that Unilever’s “valuation remains relatively stretched”: the forward P/E is close to 20 at a share price of 2,563p.

G A Chester has no position in any shares mentioned. The Motley Fool owns shares of Unilever and Tesco.

More on Investing Articles

Middle-aged white man pulling an aggrieved face while looking at a screen
Market Movers

Down 7%! Why on earth are Imperial Brands shares plummeting today?

Imperial Brands shares are in freefall after a negative reception to fresh trading news. Is the party finally over for…

Read more »

Rear View Of Woman Holding Man Hand during travel in cappadocia
Investing Articles

With a P/E under 7, this value stock looks far too cheap at 101p

This writer reckons value stock Hostelworld (LSE:HSW) looks dirt-cheap as it gets dividends flowing again and builds a social travel…

Read more »

Thoughtful man using his phone while riding on a train and looking through the window
Investing For Beginners

Down 30% in 6 months, I think there’s a big catch to this insanely cheap stock

Jon Smith talks through why careful research is needed when trying to assess if a cheap stock is worth buying…

Read more »

Investing Articles

£5,000 invested in National Grid shares 5 years ago is now worth…

Andrew Mackie takes a closer look at National Grid shares and why short-term market weakness could be missing a powerful…

Read more »

DIVIDEND YIELD text written on a notebook with chart
Investing Articles

How big does an ISA need to be to aim for a £1,500 monthly second income?

Harvey Jones shows how building a balanced portfolio of FTSE 100 dividend stocks can produce a high-and-rising second income in…

Read more »

Person holding magnifying glass over important document, reading the small print
Investing Articles

£20,000 invested in BP shares 1 year ago is now worth…

BP shares have rocketed in the past 12 months, yet analysts think the real growth story is only just beginning,…

Read more »

A pastel colored growing graph with rising rocket.
Investing Articles

A 6.8% forecast yield! 1 often-overlooked FTSE 100 income stock to buy today?

This income stock offers a high forecast yield and strengthening momentum, yet many investors overlook it — creating a rare…

Read more »

GSK scientist holding lab syringe
Investing Articles

GSK’s share price is under £22, but with a ‘fair value’ much higher, is it time for me to buy more right now? 

GSK’s share price rose over the last year, but a huge gap remains between its price and fair value —…

Read more »